Corticosteroid Therapy Guidelines
Disease-Specific Recommendations
- The American Society of Hematology strongly recommends against prolonged courses (>6 weeks) of prednisone and favors short courses (≤6 weeks) for patients with Immune Thrombocytopenia (ITP) 1, 2
- For patients with ITP requiring additional therapy after an initial 6-week course, consideration of alternative therapy is preferred over ongoing exposure to corticosteroids 1, 2
- The British Society of Gastroenterology suggests offering systemic corticosteroids for no longer than 8 weeks for patients with Inflammatory Bowel Disease (Crohn's Disease) 3, 4
- Repeated courses of steroids should be avoided unless futility of other effective therapies has been established and surgical options are not available for patients with Crohn's Disease 3, 4
- For relapses of nephrotic syndrome, the KDIGO guidelines suggest that if a 6-month cyclical corticosteroid/alkylating-agent regimen was used for initial therapy, the regimen should be repeated only once for treatment of a relapse in patients with Membranous Nephropathy 5
- In children with membranous nephropathy, no more than one course of the cyclical corticosteroid/alkylating-agent regimen should be given 5
General Principles for Minimizing Harm
- Courses longer than 6 weeks are associated with a large risk of harm and likelihood of adverse events, including hypertension, hyperglycemia, sleep and mood disturbances, gastric irritation, glaucoma, myopathy, and osteoporosis 1, 2, 6
- The risk of adverse effects increases significantly with doses >20 mg/day for more than 18 months, with severe adverse effects occurring in about 15% of patients 6
Critical Pitfalls to Avoid
- Do not use arbitrary time intervals between courses—the decision should be based on disease response, alternative treatment options, and cumulative steroid exposure 1, 2, 3, 4
- Do not continue corticosteroids beyond 6-8 weeks without reassessing the need for alternative immunosuppressive therapy 1, 2, 3, 4
- Monitor for infection risk, particularly with doses ≥20 mg prednisone-equivalent for ≥4 weeks, and consider Pneumocystis jirovecii pneumonia prophylaxis 6